Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer

NCT02024633 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: icotinib
DRUG: Gemcitabine

Sponsor

Betta Pharmaceuticals Co., Ltd.